GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ATRC
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

AtriCure stock price down 0.256% on Thursday
(Updated on Apr 18, 2024)

Sell candidate since Mar 12, 2024 Loss -33.08% PDF

The AtriCure stock price fell by -0.256% on the last day (Thursday, 18th Apr 2024) from $23.45 to $23.39. During the last trading day the stock fluctuated 3.36% from a day low at $22.90 to a day high of $23.67. The price has been going up and down for this period, and there has been a -10.55% loss for the last 2 weeks. Volume has increased on the last day by 195 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 855 thousand shares were bought and sold for approximately $19.99 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $22.44 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -22.45% during the next 3 months and, with a 90% probability hold a price between $17.40 and $25.69 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ATRC Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, April 15, 2024, and so far it has risen 2.14%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The AtriCure stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $24.02 and $30.16. A break-up above any of these levels will issue buy signals. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for AtriCure stock

AtriCure finds support from accumulated volume at $23.10 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.770 between high and low, or 3.36%. For the last week, the stock has had daily average volatility of 5.07%.

AtriCure is oversold on RSI14 (18). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ATRC) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect AtriCure to open at $23.32, and during the day (based on 14 day Average True Range), to move between $22.10 and $24.68, which gives a possible trading interval of +/-$1.29 (+/-5.51%) up or down from last closing price. If AtriCure takes out the full calculated possible swing range there will be an estimated 11.01% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $23.10 (1.24%) than the resistance at $26.48 (13.21%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is AtriCure stock A Buy?

AtriCure holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.112 Sell Candidate Unchanged

Predicted Opening Price for AtriCure of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$23.32 ( 0.299%) $23.39

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ATRC

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 24.09 2.99 %
R2 23.80 1.74 %
R1 23.61 0.96 %
Current price: 23.39
Support S1 23.03 -1.56 %
S2 22.84 -2.33 %
S3 22.55 -3.59 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 29.09 24.37 %
R2 27.61 18.04 %
R1 26.48 13.21 %
Current price 23.39
Support S1 23.10 -1.24%
S2 22.90 -2.09%
S3 0 .

FAQ

What is the symbol for AtriCure Stock and on which exchange is it traded?
The symbol for AtriCure is ATRC and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell AtriCure Stock?
AtriCure holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy AtriCure Stock?
AtriCure Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy AtriCure Stock.

What's the current price of AtriCure Stock?
As of the end of day on the 2024-04-18, the price of an AtriCure (ATRC) share was $23.39.

What is the 52-week high and low for AtriCure Stock?
The 52-week high for AtriCure Stock is $59.61 and the 52-week low is $22.42.

What is the market capitalization of AtriCure Stock?
As of the 2024-04-18, the market capitalization of AtriCure is 1.134B.

When is the next earnings date for AtriCure?
The upcoming earnings date for AtriCure is May 01, 2024.
Click to get the best stock tips daily for free!

About AtriCure

AtriCure AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform tem... ATRC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT